Stock listing

Moleculin Biotech, Inc.

Selected listing: A41SET · LS · EUR · DE

Moleculin Biotech, Inc. (Lang & Schwarz: A41SET), Health Technology. Latest release Sep 29, 2026: Moleculin Biotech Completes Enrollment in Part A of Phase…

A41SET:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A41SET
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Moleculin Biotech, Inc.

Moleculin Biotech Completes Enrollment in Part A of Phase 2/3 R/R AML MIRACLE Trial, Keeping Program on Track for Q1 2027 Data Readout

September 28, 2026

Moleculin Announces Publication of Peer-Reviewed Cardiac Safety Analysis of Annamycin in Frontiers in Cardiovascular Medicine

September 28, 2026

Annamycin Turns “Cold” Pancreatic Tumors “Hot” in New Preclinical Data Presented at AACR

September 25, 2026

Moleculin Biotech Secures Mexican Patent Protecting Lung-Targeted Liposomal Annamycin Through 2040

September 23, 2026

Moleculin Presentation from H.C. Wainwright Conference Now Available On-Demand

September 11, 2026

All Moleculin Biotech, Inc. news →

Events

Replays

Moleculin Biotech, Inc. (MBRX) Q1 2025 Earnings Call
Wed, May 14, 2025 · 08:30 AM ET
Watch
Moleculin Biotech, Inc. (MBRX) Q4 2024 Earnings Call
Mon, Mar 24, 2025 · 08:30 AM ET
Watch
Moleculin Biotech, Inc. (MBRX) Q3 2024 Earnings Call
Mon, Nov 11, 2024 · 08:30 AM ET
Watch

Research Moleculin Biotech, Inc.

Moleculin Biotech, Inc. company profile

View the public company page for Moleculin Biotech, Inc. on 6ix.

Moleculin Biotech, Inc. news

Read company news and market updates connected to Moleculin Biotech, Inc..

Moleculin Biotech, Inc. investor events

Find investor webinars, events, and replay context for Moleculin Biotech, Inc..